Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrix™ Capsules in Subjects With Osteoarthritis of the Knee or Hip

NCT01801735 is registered in ClinicalTrials.gov with Iroko Pharmaceuticals, LLC as lead sponsor.

NCT NCT01801735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01801735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrix™ Capsules in Subjects With Osteoarthritis of the Knee or Hip
Lead sponsor
Iroko Pharmaceuticals, LLC
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
August 31, 2014
Enrollment
600 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis